Weill Cornell Medicine-New York — New York, New York

Weill Cornell Medicine-New York is a clinical research site located in New York, New York, United States 10065.

Crixeo Health Trust Score: 47/100 (POOR). This profile has not yet been claimed by the site owner.

Weill Cornell Medicine-New York has participated in 1 clinical trials.

Therapeutic areas: HER2-positive Breast Cancer, HER-2 Protein Overexpression, HER-2 Gene Amplification.

Sponsors: Orum Therapeutics USA, Inc..

Sponsor Feasibility Report

Trust Score: 47/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Weill Cornell Medicine-New York?

Weill Cornell Medicine-New York has a Crixeo Trust Score of 47/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Weill Cornell Medicine-New York conducted?

Weill Cornell Medicine-New York has 1 clinical trials on record. Their work covers HER2-positive Breast Cancer, HER-2 Protein Overexpression, HER-2 Gene Amplification.

Is Weill Cornell Medicine-New York accredited by Crixeo Health?

Weill Cornell Medicine-New York has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Weill Cornell Medicine-New York?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.